A Study to Compare the Pharmacokinetics and Safety of Optivate® and Haemate P® in Patients With Von Willebrand Disease.

NCT02250508 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

OTHER

Sponsor class

Conditions

vonWillebrand's Disease

Interventions

BIOLOGICAL: Optivate® (Human Coagulation Factor VIII)
BIOLOGICAL: Haemate P® (Human Coagulation Factor VIII)

Sponsor

Bio Products Laboratory